Victory Capital Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-8,064
| Closed | -$1.98M | – | 2759 |
|
|
2022
Q3 | $1.98M | Sell |
8,064
-14,111
| -64% | -$3.47M | ﹤0.01% | 1453 |
|
|
2022
Q2 | $5.49M | Sell |
22,175
-328
| -1% | -$81.2K | 0.01% | 1226 |
|
|
2022
Q1 | $6.45M | Buy |
22,503
+1,659
| +8% | +$475K | 0.01% | 1248 |
|
|
2021
Q4 | $7.49M | Sell |
20,844
-79
| -0.4% | -$28.4K | 0.01% | 1213 |
|
|
2021
Q3 | $6.81M | Sell |
20,923
-531
| -2% | -$173K | 0.01% | 1225 |
|
|
2021
Q2 | $6.7M | Sell |
21,454
-27,264
| -56% | -$8.51M | 0.01% | 1247 |
|
|
2021
Q1 | $15.5M | Buy |
48,718
+2,114
| +5% | +$674K | 0.02% | 1000 |
|
|
2020
Q4 | $15.1M | Sell |
46,604
-14,921
| -24% | -$4.84M | 0.02% | 986 |
|
|
2020
Q3 | $17M | Buy |
61,525
+46,973
| +323% | +$13M | 0.02% | 873 |
|
|
2020
Q2 | $3.52M | Sell |
14,552
-12,890
| -47% | -$3.11M | ﹤0.01% | 1259 |
|
|
2020
Q1 | $3.98M | Buy |
27,442
+10,239
| +60% | +$1.49M | ﹤0.01% | 1339 |
|
|
2019
Q4 | $2.94M | Sell |
17,203
-185,946
| -92% | -$31.7M | ﹤0.01% | 1363 |
|
|
2019
Q3 | $36.1M | Buy |
203,149
+104,400
| +106% | +$18.6M | 0.05% | 570 |
|
|
2019
Q2 | $25.7M | Sell |
98,749
-108,053
| -52% | -$28.1M | 0.05% | 525 |
|
|
2019
Q1 | $59.1M | Buy |
206,802
+48,771
| +31% | +$13.9M | 0.13% | 220 |
|
|
2018
Q4 | $51.4M | Sell |
158,031
-15,408
| -9% | -$5.01M | 0.13% | 229 |
|
|
2018
Q3 | $78M | Buy |
173,439
+37,948
| +28% | +$17.1M | 0.16% | 162 |
|
|
2018
Q2 | $55.4M | Buy |
135,491
+45,188
| +50% | +$18.5M | 0.12% | 262 |
|
|
2018
Q1 | $26.3M | Buy |
90,303
+79,326
| +723% | +$23.1M | 0.06% | 507 |
|
|
2017
Q4 | $2.06M | Buy |
10,977
+1,237
| +13% | +$232K | ﹤0.01% | 1020 |
|
|
2017
Q3 | $1.64M | Sell |
9,740
-21
| -0.2% | -$3.54K | ﹤0.01% | 1063 |
|
|
2017
Q2 | $1.4M | Buy |
9,761
+1,738
| +22% | +$249K | ﹤0.01% | 1081 |
|
|
2017
Q1 | $1M | Buy |
8,023
+3,009
| +60% | +$377K | ﹤0.01% | 1171 |
|
|
2016
Q4 | $565K | Buy |
5,014
+584
| +13% | +$65.8K | ﹤0.01% | 1257 |
|
|
2016
Q3 | $570K | Buy |
+4,430
| New | +$570K | ﹤0.01% | 1221 |
|